Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
MCO heads into its October 20 earnings release with analysts pulling targets lower across the board, even as the stock has recovered to within striking distance of the most cautious Street estimates.
The target-cutting has been broad and consistent this week. RBC Capital lowered its target to $575 from $610 on Thursday while holding its Outperform rating. JP Morgan trimmed to $555 from $570 on Tuesday, also maintaining Overweight. Morgan Stanley cut to $470 from $512 last week, the most bearish on the Street at roughly current price levels. BMO sits close behind at $490, matching the stock's $485 close. The mean target across the consensus is $551, about 14% above the current price, but the direction of travel in the final days before the print is unmistakably downward. Since the previous note published October 14, short interest has eased slightly, with the daily estimate slipping from around 2.8 million shares to 2.74 million, a modest reversal of the week-on-week build described then. That does not alter the broader trend: shorts are still up roughly 15% on the month and cost to borrow has ticked up 22% on the week to 0.54%, though it remains a low absolute level. Borrow availability is effectively unlimited, with shares available to lend running at more than 75 times the current short position, so there is no mechanical pressure on the short side.
The bull-versus-bear debate on MCO centres on the durability of credit issuance volumes. Bulls point to the strength in Moody's Investors Service, where billed issuance grew 23% year-over-year as recently as August, with MIS revenue expected by some to reach $1.1 billion, a double-digit beat over consensus. The Moody's Analytics segment is the contested ground: bears argue that account losses and strategic terminations have exposed a structural softness in demand, while bulls see cross-selling from new product launches and decision solutions as a growing offset. Valuation offers little comfort to either camp: the stock trades at roughly 26 times earnings and 21 times EV/EBITDA, with both multiples drifting higher over the past month. The EV/EBITDA multiple is up nearly 0.7 turns in 30 days, meaning the stock has re-rated modestly upward even as analysts have been trimming.
The ownership picture adds one genuinely notable data point. Berkshire Hathaway remains the largest disclosed holder at 14.2% of shares, a long-standing and unchanged position as of June. TCI Fund Management holds 8.2%. Neither has moved materially in recent filings. Institutional breadth is wide, with 306 holders on record, and no 13D activist is on the register. The activist disclosure note carries the standard caveat: stakes are as last disclosed around the 5% threshold, and holders dropping below that level need not file again.
On past earnings, MCO fell 3.8% in the session after its July 2026 print and was still down 1.5% five days later. The prior quarter saw a 3.1% one-day drop followed by a 4.2% five-day decline. The pattern has been consistently negative in the immediate aftermath of results, which makes the extent to which Tuesday's report clarifies the Analytics growth question, and the MIS pipeline into year-end, the central test for the stock.
See the live data behind this article on ORTEX.
Open MCO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
